Clinical Trial Update: Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether switching from COMBIGAN (brimonidine/timolol) to AZARGA (brinzolamide/timolol) improves efficacy and tolerability in glaucoma p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Azarga (brinzolamide; timolol maleate)
• Combigan (brimonidine tartrate and timolol maleate)

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma | Phase 4 | Status: COMPLETED | Results posted: 2014-04-04